|
1.
|
|
12 p, 804.5 KB |
RIC versus MAC UCBT in adults with AML : A report from Eurocord, the ALWP and the CTIWP of the EBMT
/
Baron, Frédéric (University of Liege) ;
Ruggeri, Annalisa (Hôpital Saint-Antoine (Paris, França)) ;
Beohou, Eric (Hôpital Saint-Antoine (Paris, França)) ;
Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ;
Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ;
Milpied, Noel (University of Bordeaux) ;
Michallet, Mauricette (Centre Hospitalier de Lyon Sud) ;
Bacigalupo, Andrea (Ospedale San Martino) ;
Blaise, Didier (Aix-Marseille Université) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Socié, Gérard (Hospital Saint-Louis) ;
Cornelissen, Jan J. (Erasmus Medical Center-Daniel den Hoed Cancer Center) ;
Schmid, Christoph (University of Munich) ;
Giebel, Sebastian (Gliwice Branch) ;
Gorin, Norbert-Claude (Hospital Saint Antoine) ;
Esteve, Jordi (Hematology. Hospital Clinic) ;
Ciceri, Fabio (Ospedale San Raffaele) ;
Savani, Bipin N. (Vanderbilt University Medical Center) ;
Mohty, Mohamad (UMRs 938) ;
Gluckman, Eliane (Centre Scientifique de Monaco) ;
Nagler, Arnon (The Chaim Sheba Medical Center) ;
Universitat Autònoma de Barcelona
Nonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patients and those with medical comorbidities to benefit from UCBT. [...]
2016 -  10.18632/oncotarget.9599
Oncotarget, Vol. 7 Núm. 28 (2016) , p. 43027-43038
|
|
|
2.
|
|
6 p, 657.1 KB |
Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation : A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study
/
Paviglianiti, Annalisa (Centre Scientifique de Monaco) ;
Tozatto Maio, Karina (Centre Scientifique de Monaco) ;
Rocha, Vanderson (Hospital Sao Paulo) ;
Gehlkopf, Eve (CHU Lapeyronie) ;
Milpied, Noel (CHU Bordeaux) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ;
Blaise, Didier (Institute Paoli Calmettes) ;
Gac, Anne-Claire (Institut d'Hématologie de Basse-Normandie) ;
Leblond, Véronique (Hopital la Pitié-Salpêtrière) ;
Cahn, Jean-Yves (CHU Grenoble Alpes) ;
Abecasis, Manuel (Institute Portugues Oncologia) ;
Zuckerman, Tsila (Rambam Medical Center) ;
Schouten, Harry (University Hospital Maastricht) ;
Gurman, Gunhan (Ankara University) ;
Rubio, Marie Thérèse (Hôpitaux des Brabois) ;
Beguin, Yves (CHU of Liège and University of Liege) ;
Corral, Lucia Lopez (Centro de Investigacion del Cancer-IBMCC) ;
Nagler, Amon (Chaim Sheba Medical Center (Israel)) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Trust) ;
Koc, Yener (Stem Cell Transplant Unit Medical Park Hospitals) ;
Mordini, Nicola (Az. Ospedaliera S. Croce e Carle) ;
Bonifazi, Francesca ("Seragnoli" University Hospital S. Orsola-Malpighi) ;
Volt, Fernanda (Centre Scientifique de Monaco) ;
Kenzey, Chantal (Centre Scientifique de Monaco) ;
Robinson, Stephen Paul (EBMT Lymphoma Working Party) ;
Montoto, Silvia (EBMT Lymphoma Working Party) ;
Gluckman, Eliane (Centre Scientifique de Monaco) ;
Ruggeri, Annalisa (Bambin Gesù) ;
Universitat Autònoma de Barcelona
Allogeneic stem cell transplantation is an alternative for patients with relapsed or refractory Hodgkin lymphoma (HL), but only limited data on unrelated umbilical cord blood transplantation (UCBT) are available. [...]
2018 - 10.1016/j.bbmt.2018.07.019
Biology of blood and marrow transplantation, Vol. 24 Núm. 11 (november 2018) , p. 2265-2270
|
|
|
3.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
4.
|
|
11 p, 858.6 KB |
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation
/
Baron, Frederic (Université de Liège (Bèlgica)) ;
Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ;
Ruggeri, Annalisa (Hôpital Saint-Louis (Paris, França)) ;
Mohty, Mohamad (Hôpital Saint-Antoine (Paris, França)) ;
Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ;
Milpied, Noel (Hôpital Haut Léveque (Pessac, França)) ;
Bacigalupo, Andrea (Ospedale Sant Martino (Genova, Itàlia)) ;
Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Itàlia)) ;
Bonifazi, Francesca (Policlinico Sant'Orsola-Malpighi (Bologna, Itàlia)) ;
Bosi, Alberto (Azienda Ospedaliero Universitaria Careggi (Firenze, Itàlia)) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Yakoub-Agha, Ibrahim (Hôpital Claude Huriez (Lille, França)) ;
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Gluckman, Eliane (Hôpital Saint-Louis (Paris, França)) ;
Nagler, Arnon (Sheba Medical Center (Ramat Gran, Israel)) ;
Universitat Autònoma de Barcelona
BACKGROUND: In the setting of allogeneic human leukocyte antigen (HLA)-matched bone marrow transplantation, transplanting male patients with grafts from female donors has been associated with a higher incidence of graft-versus-host disease (GVHD) and of nonrelapse mortality (NRM). [...]
2015 - 10.1186/s13045-015-0207-4
Journal of hematology & oncology, Vol. 8 Núm. 107 (october 2015)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
